MAPT and Alzheimer disease: But, the safe redundancy of tau and APP is unlikely because the adverse phenotypes relevant for neurodegeneration, particularly those related to brain metal dyshomeostasis, are, like AD itself, a product of aging and do not emerge until the postreproductive epoch (9, 10, 11, 12).